49349-624 : Invirase 200 mg Oral Capsule
| NDC: | 49349-624 |
| Labeler: | Remedyrepack Inc. |
| Product Type: | Human Prescription Drug |
| Drug Name: |  Invirase |
| Dosage Form: | Oral Capsule |
| Application #: | NDA020628 |
| Rev. Date: |
Appearance:
| Markings: | ROCHE;0245 |
| Shapes: |
Capsule |
| Colors: |
 Brown |
| Size (mm): | 22 |
| Segments: * | 1 |
* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines. | |
NDC Package Codes:
- 49349-624-37: 135 CAPSULE IN 1 BLISTER PACK (49349‑624‑37)
Active Ingredients:
- Saquinavir Mesylate
Dosage Strength:
- 200 mg
Inactive Ingredients:
- Anhydrous Lactose
- Ferric Oxide Red
- Ferric Oxide Yellow
- Fd&c Blue No. 2
- Ferrosoferric Oxide
- Water
- Gelatin
- Cellulose, Microcrystalline
- Magnesium Stearate
- Povidone K30
- Sodium Starch Glycolate Type a Potato
- Talc
- Titanium Dioxide
Pharmaceutical Classes:
- HIV Protease Inhibitors [MoA]
- Protease Inhibitor [EPC]
- Cytochrome P450 3A Inhibitors [MoA]
Related Products:
Based on records with the same trade name.- 0004-0244 Invirase 500 mg Oral Tablet by Genentech, Inc.
- 0004-0245 Invirase 200 mg Oral Capsule by Genentech, Inc.
- 53808-0674 Invirase 500 mg Oral Tablet by State of Florida Doh Central Pharmacy
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 49349-623Next: 49349-625 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.